Apex Medical Initiative Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.85 Cr
as on 12-12-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.25 Cr
as on 12-12-2024
About Apex Medical Initiative
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.85 Cr.
The company currently has active open charges totaling ₹8.25 Cr.
Arvind Kulkarni, Sarita Kulkarni, Anagha Kulkarni, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85190MH2021PTC367774
- Company No.
367774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apex Medical Initiative?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aashay Kekatpure  | Director | 20-Sep-2021 | Current |
| Arvind Kulkarni | Director | 29-Nov-2022 | Current |
| Sarita Kulkarni | Director | 29-Nov-2022 | Current |
| Anagha Kulkarni | Director | 20-Sep-2021 | Current |
| Kalyani Kulkarni | Director | 29-Nov-2022 | Current |
| Anurag Kulkarni | Director | 29-Nov-2022 | Current |
Financial Performance of Apex Medical Initiative.
Enhance accessibility to Apex Medical Initiative's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Apex Medical Initiative?
Unlock access to Apex Medical Initiative's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Deepkalyani Infrastructures Private LimitedActive 3 years 2 monthsArvind Kulkarni and Sarita Kulkarni are mutual person
- Deepkalyani Hospitalities Private LimitedActive 28 years 11 months
Arvind Kulkarni, Sarita Kulkarni and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Apr 2023 | ₹8.25 Cr | Open |
How Many Employees Work at Apex Medical Initiative?
Apex Medical Initiative has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Medical Initiative, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Medical Initiative's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
